BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Rachel Abraham, Banumathi Ramakrishna, Avinash Balekuduru, Hubert Darius J. Daniel, Priya Abraham, C. Eapen Eapen, George Kurian. Clinicopathological features and genotype distribution in patients with hepatitis C virus chronic liver diseaseIndian Journal of Gastroenterology 2009; 28(2): 53 doi: 10.1007/s12664-009-0018-z
2
Yasir Waheed. Effect of interferon plus ribavirin therapy on hepatitis C virus genotype 3 patients from Pakistan: Treatment response, side effects and future prospectiveAsian Pacific Journal of Tropical Medicine 2015; 8(2): 85 doi: 10.1016/S1995-7645(14)60193-0
3
Ahmed A. Al-Qahtani, George Kessie, Damian Dela Cruz, Faleh Z. Al-Faleh, Mohammed N. Al-Ahdal. Quasispecies of genotype 4 of hepatitis C virus genomes in Saudi patients managed with interferon alfa and ribavirin therapyAnnals of Saudi Medicine 2010; 30(2): 109 doi: 10.4103/0256-4947.60515
4
Cíntia Bittar, Ana Carolina Gomes Jardim, Lilian Hiromi Tomonari Yamasaki, Claudia Márcia Aparecida Carareto, João Renato Rebello Pinho, Philippe Lemey, Isabel Maria Vicente Guedes de Carvalho-Mello, Paula Rahal, Michael Alan Polis. On Hepatitis C Virus Evolution: The Interaction between Virus and Host towards Treatment OutcomePLoS ONE 2013; 8(4): e62393 doi: 10.1371/journal.pone.0062393
5
Juliet A. Shenge, Georgina N. Odaibo, David O. Olaleye, Jason Blackard. Phylogenetic analysis of hepatitis C virus among HIV/ HCV co-infected patients in NigeriaPLOS ONE 2019; 14(2): e0210724 doi: 10.1371/journal.pone.0210724
6
Shanmugam Saravanan, Vijayakumar Velu, Nagalingeswaran Kumarasamy, Esaki Muthu Shankar, Subhadra Nandakumar, Kailapuri G. Murugavel, Pachamuthu Balakrishnan, Sunil Suhas Solomon, Suniti Solomon, Sadras Panchatcharam Thyagarajan. The prevalence of hepatitis B virus and hepatitis C virus infection among patients with chronic liver disease in South IndiaInternational Journal of Infectious Diseases 2008; 12(5): 513 doi: 10.1016/j.ijid.2008.02.006
7
M. A. Maqbool, M. R. Imache, M. R. Higgs, S. Carmouse, J.-M. Pawlotsky, H. Lerat. Regulation of Hepatitis C Virus Replication by Nuclear Translocation of Nonstructural 5A Protein and Transcriptional Activation of Host GenesJournal of Virology 2013; 87(10): 5523 doi: 10.1128/JVI.00585-12
8
Chikako Yamamoto, Shintaro Nagashima, Channarena Chuon, Ko Ko, Son Huy Do, Oline Lim, Sirany Hok, Somana Svay, Junko Matsuo, Keiko Katayama, Kazuaki Takahashi, Junko Tanaka. Substitution of the CD81 Binding Site and β-Sandwich Area in E2 of HCV in CambodiaViruses 2020; 12(5): 551 doi: 10.3390/v12050551
9
Cíntia Bittar, Ana Carolina G Jardim, Lilian HT Yamasaki, Artur TL de Queiróz, Claudia MA Carareto, João Renato R Pinho, Isabel Maria VG de Carvalho-Mello, Paula Rahal. Genetic diversity of NS5A protein from hepatitis C virus genotype 3a and its relationship to therapy responseBMC Infectious Diseases 2010; 10(1) doi: 10.1186/1471-2334-10-36
10
Claire Gondeau, Lydiane Pichard-Garcia, Patrick Maurel. Cellular models for the screening and development of anti-hepatitis C virus agentsPharmacology & Therapeutics 2009; 124(1): 1 doi: 10.1016/j.pharmthera.2009.05.010
11
Jan Paeshuyse, Inge Vliegen, Lotte Coelmont, Pieter Leyssen, Oriana Tabarrini, Piet Herdewijn, Harald Mittendorfer, Johnny Easmon, Violetta Cecchetti, Ralf Bartenschlager, Gerhard Puerstinger, Johan Neyts. Comparative In Vitro Anti-Hepatitis C Virus Activities of a Selected Series of Polymerase, Protease, and Helicase InhibitorsAntimicrobial Agents and Chemotherapy 2008; 52(9): 3433 doi: 10.1128/AAC.01534-07
12
Qing Ge, John J Xu, David M Evans, A James Mixson, Harry Y Yang, Patrick Y Lu. Leveraging therapeutic potential of multi-targeted siRNA inhibitorsFuture Medicinal Chemistry 2009; 1(9): 1671 doi: 10.4155/fmc.09.131
13
Phyllis T. Losikoff, Alyssa A. Self, Stephen H. Gregory. Dendritic cells, regulatory T cells and the pathogenesis of chronic hepatitis CVirulence 2012; 3(7): 610 doi: 10.4161/viru.21823
14
Pierina D’Angelo, Rossana Celeste Jaspe, Carmen Luisa Loureiro, Cristina Gutiérrez, María Zulay Sulbarán, Yoneira Sulbarán, Felix Toro, Flor Helene Pujol. Desempeño de métodos moleculares para la identificación de subtipos poco comunes del virus de hepatitis C genotipo 2Biomédica 2018; 38(2): 282 doi: 10.7705/biomedica.v38i0.3864
15
Vinod K Rustgi. Safety of small molecules in combination with interferon-based therapy for hepatitis C virusExpert Opinion on Drug Safety 2010; 9(6): 883 doi: 10.1517/14740338.2010.495942
16
Fernando González-Candelas, F Xavier López-Labrador. Clinical relevance of genetic heterogeneity in HCVFuture Virology 2010; 5(1): 33 doi: 10.2217/fvl.09.63
17
Moataza H. Omran, Wael Nabil, Samar S. Youssef, Mervat El-Sayed, Mostafa K. El Awady. Heterogeneity and New Epitopes of Hepatitis C Virus Genotype 4Hepatitis Monthly 2013; 13(8) doi: 10.5812/hepatmon.10521
18
Guilherme Rodrigues Fernandes Campos, Cíntia Bittar, Ana Carolina Gomes Jardim, Jacqueline Farinha Shimizu, Mariana Nogueira Batista, Eder Ramos Paganini, Letícia Ribeiro de Assis, Christopher Bartlett, Mark Harris, Vanderlan da Silva Bolzani, Luis Octavio Regasini, Paula Rahal. Hepatitis C virus in vitro replication is efficiently inhibited by acridone Fac4 Journal of General Virology 2017; 98(7): 1693 doi: 10.1099/jgv.0.000808
19
Sandra Ciesek, Thomas Hahn. Relevance of Resistance Against Direct Acting Antiviral Agents in Hepatitis C Virus Infection – What Technology do we Really Need in Clinical Practice?Current Hepatitis Reports 2013; 12(4): 195 doi: 10.1007/s11901-013-0185-3
20
Philippe Halfon, Stephen Locarnini. Hepatitis C virus resistance to protease inhibitorsJournal of Hepatology 2011; 55(1): 192 doi: 10.1016/j.jhep.2011.01.011
21
H.-M. Lin, J.-C. Wang, H.-S. Hu, P.-S. Wu, W.-H. Wang, S.-Y. Wu, C.-C. Yang, T.-K. Yeh, T.-A. Hsu, W.-T. Jiaang, Y.-S. Chao, J.-H. Chern, A. Yueh. Resistance Studies of a Dithiazol Analogue, DBPR110, as a Potential Hepatitis C Virus NS5A Inhibitor in Replicon SystemsAntimicrobial Agents and Chemotherapy 2013; 57(2): 723 doi: 10.1128/AAC.01403-12
22
Ashraf A. Tabll, Khaled Atef, Noha G. Bader El Din, Yasmine S. El Abd, Ahmed Salem, Ahmed A. Sayed, Reham M. Dawood, Moataza H. Omran, Mostafa K. El-Awady. IN VITRONEUTRALIZATION OF HCV BY GOAT ANTIBODIES AGAINST PEPTIDES ENCOMPASSING REGIONS DOWNSTREAM OF HVR-1 OF E2 GLYCOPROTEINJournal of Immunoassay and Immunochemistry 2014; 35(1): 12 doi: 10.1080/15321819.2013.779925
23
Sobia Kanwal, Tariq Mahmood. Occurrence of genetic modifications in core, 5′UTR and NS5b of HCV associated with viral response to treatmentVirology Journal 2014; 11(1) doi: 10.1186/1743-422X-11-171
24
Lize Cuypers, Guangdi Li, Pieter Libin, Supinya Piampongsant, Anne-Mieke Vandamme, Kristof Theys. Genetic Diversity and Selective Pressure in Hepatitis C Virus Genotypes 1–6: Significance for Direct-Acting Antiviral Treatment and Drug ResistanceViruses 2015; 7(9): 5018 doi: 10.3390/v7092857
25
Angela M. Lam, Eisuke Murakami, Christine Espiritu, Holly M. Micolochick Steuer, Congrong Niu, Meg Keilman, Haiying Bao, Veronique Zennou, Nigel Bourne, Justin G. Julander, John D. Morrey, Donald F. Smee, David N. Frick, Julie A. Heck, Peiyuan Wang, Dhanapalan Nagarathnam, Bruce S. Ross, Michael J. Sofia, Michael J. Otto, Phillip A. Furman. PSI-7851, a Pronucleotide of β-d-2′-Deoxy-2′-Fluoro-2′-C-Methyluridine Monophosphate, Is a Potent and Pan-Genotype Inhibitor of Hepatitis C Virus Replication Antimicrobial Agents and Chemotherapy 2010; 54(8): 3187 doi: 10.1128/AAC.00399-10
26
Mozhgan Afrasiabi, Seyed Younes Hosseini, Ramin Yaghobi, Mohammad-Reza Fattahi, Maryam Ardebili, Mahboobeh Khodadad. Analysis of Naturally Occurring Resistant Mutations to Hepatitis C Virus NS3 Protease Inhibitors: A Preliminary Study in South of IranJundishapur Journal of Microbiology 2015; 8(10) doi: 10.5812/jjm.24965
27
M Carrozzo. Oral diseases associated with hepatitis C virus infection. Part 1. sialadenitis and salivary glands lymphomaOral Diseases 2008; 14(2): 123 doi: 10.1111/j.1601-0825.2007.01436.x
28
Natalia Echeverría, Pilar Moreno, Juan Cristina. Human Virology in Latin America2017; : 333 doi: 10.1007/978-3-319-54567-7_17
29
Jing Xu, Shufeng Liu, Yihui Xu, Po Tien, Guangxia Gao. Identification of the nonstructural protein 4B of hepatitis C virus as a factor that inhibits the antiviral activity of interferon-alphaVirus Research 2009; 141(1): 55 doi: 10.1016/j.virusres.2009.01.001
30
Hanadi Qashqari, Amany Al-Mars, Adeel Chaudhary, Adel Abuzenadah, Ghazi Damanhouri, Mohammed Alqahtani, Maged Mahmoud, Maysaa El Sayed Zaki, Kaneez Fatima, Ishtiaq Qadri. Understanding the molecular mechanism(s) of hepatitis C virus (HCV) induced interferon resistanceInfection, Genetics and Evolution 2013; 19: 113 doi: 10.1016/j.meegid.2013.06.025
31
Myriam Lereau, Chantal Fournier-Wirth, Julie Mayen, Carole Farre, Albert Meyer, Vincent Dugas, Jean-François Cantaloube, Carole Chaix, Jean-Jacques Vasseur, François Morvan. Development of Innovative and Versatile Polythiol Probes for Use on ELOSA or Electrochemical Biosensors: Application in Hepatitis C Virus GenotypingAnalytical Chemistry 2013; 85(19): 9204 doi: 10.1021/ac401941x
32
Reem R Al Olaby, Hassan ME Azzazy. Hepatitis C virus RNA assays: current and emerging technologies and their clinical applicationsExpert Review of Molecular Diagnostics 2011; 11(1): 53 doi: 10.1586/erm.10.101
33
Juliana Cristina Santiago Bastos, Marina Aiello Padilla, Leonardo Cardia Caserta, Noelle Miotto, Aline Gonzalez Vigani, Clarice Weis Arns. Hepatitis C virus: Promising discoveries and new treatmentsWorld Journal of Gastroenterology 2016; 22(28): 6393-6401 doi: 10.3748/wjg.v22.i28.6393
34
Paul Klenerman, Karen Fitzmaurice. An update on hepatitis C virusClinical Medicine 2015; 15(Suppl 6): s33 doi: 10.7861/clinmedicine.15-6-s33
35
Suhair M. Abozaid, Mohamed Shoukri, Ahmad Al-Qahtani, Mohammed N. Al-Ahdal. Prevailing genotypes of hepatitis C virus in Saudi Arabia: a systematic analysis of evidenceAnnals of Saudi Medicine 2013; 33(1): 1 doi: 10.5144/0256-4947.2013.1
36
Cristina Romero-López, Alfredo Berzal-Herranz. The 5BSL3.2 Functional RNA Domain Connects Distant Regions in the Hepatitis C Virus GenomeFrontiers in Microbiology 2017; 8 doi: 10.3389/fmicb.2017.02093
37
Thi Nhan Le, Tu Bao Ho. Intelligent Information and Database SystemsLecture Notes in Computer Science 2012; 7196: 377 doi: 10.1007/978-3-642-28487-8_39
38
Marcy Coash, George Y. Wu. Chronic Viral Hepatitis2009; : 1 doi: 10.1007/978-1-59745-565-7_1
39
Michael J Sofia. Nucleotide Prodrugs for HCV TherapyAntiviral Chemistry and Chemotherapy 2011; 22(1): 23 doi: 10.3851/IMP1797
40
Ana CG Jardim, Cíntia Bittar, Renata PA Matos, Lílian HT Yamasaki, Rafael A Silva, João RR Pinho, Roberta M Fachini, Claudia MA Carareto, Isabel MVG de Carvalho-Mello, Paula Rahal. Analysis of HCV quasispecies dynamic under selective pressure of combined therapyBMC Infectious Diseases 2013; 13(1) doi: 10.1186/1471-2334-13-61
41
Federico Bolcic, Natalia Laufer, Carolina Torres, Lucila Cassino, Rita Reynoso, Jorge Quarleri. Longitudinal analysis of the 5′UTR, E2-PePHD and NS5A-PKRBD genomic regions of hepatitis C virus genotype 1a in association with the response to peginterferon and ribavirin therapy in HIV-coinfected patientsAntiviral Research 2012; 95(2): 72 doi: 10.1016/j.antiviral.2012.05.015
42
Lize Cuypers, Guangdi Li, Christoph Neumann-Haefelin, Supinya Piampongsant, Pieter Libin, Kristel Van Laethem, Anne-Mieke Vandamme, Kristof Theys. Mapping the genomic diversity of HCV subtypes 1a and 1b: Implications of structural and immunological constraints for vaccine and drug developmentVirus Evolution 2016; 2(2): vew024 doi: 10.1093/ve/vew024
43
Zaki Maysaa El Sayed, F. A. Mansour, M. F. Ghal, S. B. Abou-Zahra. Evaluation of Interleukin-8 in Hepatitis C Virus Infection: Relation to Combined peg-interferon Ribavirin Response and Genotype 4Immunological Investigations 2011; 40(1): 29 doi: 10.3109/08820139.2010.508192
44
Michael J. Sofia, Wonsuk Chang, Phillip A. Furman, Ralph T. Mosley, Bruce S. Ross. Nucleoside, Nucleotide, and Non-Nucleoside Inhibitors of Hepatitis C Virus NS5B RNA-Dependent RNA-PolymeraseJournal of Medicinal Chemistry 2012; 55(6): 2481 doi: 10.1021/jm201384j
45
Robert A. Fridell, Dike Qiu, Chunfu Wang, Lourdes Valera, Min Gao. Resistance Analysis of the Hepatitis C Virus NS5A Inhibitor BMS-790052 in an In Vitro Replicon System Antimicrobial Agents and Chemotherapy 2010; 54(9): 3641 doi: 10.1128/AAC.00556-10
46
J. Lara, G. Xia, M. Purdy, Y. Khudyakov. Coevolution of the Hepatitis C Virus Polyprotein Sites in Patients on Combined Pegylated Interferon and Ribavirin TherapyJournal of Virology 2011; 85(7): 3649 doi: 10.1128/JVI.02197-10
47
Nahla Fadl, Tamer Z. Salem. Hepatitis C genotype 4: A report on resistance‐associated substitutions in NS3 , NS5A , and NS5B genes Reviews in Medical Virology 2020;  doi: 10.1002/rmv.2120
48
H. Le Guillou-Guillemette, P. Calès, F. Lunel. Actualités sur les co-infections VIH–VHCAntibiotiques 2008; 10(4): 167 doi: 10.1016/j.antib.2008.08.004
49
Juan-Ramón Larrubia, Elia Moreno-Cubero, Joaquín Miquel, Eduardo Sanz-de-Villalobos. Hepatitis C virus-specific cytotoxic T cell response restoration after treatment-induced hepatitis C virus controlWorld Journal of Gastroenterology 2015; 21(12): 3480-3491 doi: 10.3748/wjg.v21.i12.3480
50
S. Justa, R.W. Minz, M. Minz, A. Sharma, S. Anand, A. Das, Y.K. Chawla, V.K. Sakhuja. Serial Measurements of Hepatitis C Viral Load by Real-Time Polymerase Chain Reaction Among Recipients of Living-Donor Renal Transplants: A Short-Term Follow-Up Study From a Single CenterTransplantation Proceedings 2010; 42(9): 3568 doi: 10.1016/j.transproceed.2010.07.102
51
Saori Kawasaki, Tu Bao Ho, Tatsuo Kanda, Osamu Yokosuka, Katsuhiro Takabayashi, Nhan Le. Knowledge, Information, and Creativity Support SystemsLecture Notes in Computer Science 2011; 6746: 79 doi: 10.1007/978-3-642-24788-0_8
52
Phillip A Furman, Angela M Lam, Eisuke Murakami. Nucleoside analog inhibitors of hepatitis C viral replication: recent advances, challenges and trendsFuture Medicinal Chemistry 2009; 1(8): 1429 doi: 10.4155/fmc.09.88
53
Medhat K. Shier, James C. Iles, Mohammad S. El-Wetidy, Hebatallah H. Ali, Mohammad M. Al Qattan, Dimitrios Paraskevis. Molecular characterization and epidemic history of hepatitis C virus using core sequences of isolates from Central Province, Saudi ArabiaPLOS ONE 2017; 12(9): e0184163 doi: 10.1371/journal.pone.0184163
54
Jakovljevic B. Mihajlo, Miјailovic D. Zeljko, Popovska Jovicic D. Biljana, Canovic S. Predrag, Gajovic M. Olgica, Jovanovic R. Mirjana, Petrovic S. Dejan, Milovanovic Z. Olivera, Djordjevic D. Natasa. Assessment of Viral Genotype Impact to the Cost-Effectiveness and Overall Costs of Care for Peg-Interferon-2α + Ribavirine Treated Chronic Hepatitis C PatientsHepatitis Monthly 2013; 13(6) doi: 10.5812/hepatmon.6750
55
Piyasena Hewawasam, Yong Tu, Min Gao, Umesh Hanumegowda, Jay Knipe, Julie A. Lemm, Dawn D. Parker, Karen L. Rigat, Susan B. Roberts, Nicholas A. Meanwell, John F. Kadow. Discovery and preclinical evaluation of potent, orally bioavailable, metabolically stable cyclopropylindolobenzazepine acylsulfonamides as thumb site 1 inhibitors of the hepatitis c virus NS5B RNA-dependent, RNA polymeraseBioorganic & Medicinal Chemistry Letters 2016; 26(3): 936 doi: 10.1016/j.bmcl.2015.12.058
56
Natalia Echeverría, Gonzalo Moratorio, Juan Cristina, Pilar Moreno. Hepatitis C virus genetic variability and evolutionWorld Journal of Hepatology 2015; 7(6): 831-845 doi: 10.4254/wjh.v7.i6.831